| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $94.6M | +34.3% |
| R&D Expense | $240.8M | +50.6% |
| SG&A Expense | $178.0M | +83.9% |
| Operating Income | -$324.2M | -74.0% |
| Interest Expense | $19.4M | +18.1% |
| Income Tax | $0 | — |
| Net Income | -$389.0M | -80.6% |
| EPS (Basic) | -$4.33 | -54.6% |
| EPS (Diluted) | -$4.33 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.6M | -41.8% |
| Accounts Receivable | $147K | -99.7% |
| Current Assets | $795.2M | +48.4% |
| Total Assets | $1.01B | +20.6% |
| Current Liabilities | $84.6M | +17.8% |
| Long-term Debt | $649.6M | +1271.3% |
| Total Liabilities | $1.12B | +87.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$299.5M | -110.2% |
| Capital Expenditures | $11.3M | -76.8% |
| Investing Cash Flow | -$262.1M | -77.4% |
| Financing Cash Flow | $516.2M | +61.3% |
| Free Cash Flow | -$310.9M | -62.4% |
| -54.6% |
| Stockholders' Equity |
| -$107.9M |
| -144.2% |